What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Alzheimer's disease
- Disease
The scientist’s investigation covers issues in Dementia, Alzheimer's disease, Internal medicine, Pathology and Audiology.
In general Dementia study, his work on Cognitive decline often relates to the realm of Association, thereby connecting several areas of interest.
Mary M. Machulda interconnects Apolipoprotein E, Psychiatry, Effects of sleep deprivation on cognitive performance and Cohort in the investigation of issues within Alzheimer's disease.
His research investigates the connection between Internal medicine and topics such as Oncology that intersect with issues in Diabetes mellitus.
The various areas that he examines in his Pathology study include Biomarker, Positron emission tomography and Magnetic resonance imaging.
The concepts of his Audiology study are interwoven with issues in Cognitive psychology, Atrophy, Apraxia, Free recall and Brain mapping.
His most cited work include:
- Non-Stationarity in the ``Resting Brain's'' Modular Architecture (297 citations)
- Comparison of memory fMRI response among normal, MCI, and Alzheimer’s patients (294 citations)
- Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72 (278 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Dementia, Pathology, Cognition and Audiology.
Mary M. Machulda works mostly in the field of Internal medicine, limiting it down to topics relating to Oncology and, in certain cases, Apolipoprotein E, as a part of the same area of interest.
His Dementia research is multidisciplinary, incorporating elements of Gerontology, Cohort study, Pediatrics and Hazard ratio.
His work carried out in the field of Pathology brings together such families of science as Positron emission tomography, Magnetic resonance imaging and Neuroimaging.
Mary M. Machulda has included themes like Primary progressive aphasia and Apraxia, Aphasia in his Audiology study.
Mary M. Machulda has researched Alzheimer's disease in several fields, including Standardized uptake value and Amyloidosis.
He most often published in these fields:
- Internal medicine (26.75%)
- Dementia (24.92%)
- Pathology (17.93%)
What were the highlights of his more recent work (between 2019-2021)?
- Dementia (24.92%)
- Cognitive decline (13.68%)
- Internal medicine (26.75%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Dementia, Cognitive decline, Internal medicine, Disease and Cognition.
His work deals with themes such as Longitudinal study and Anxiety, which intersect with Dementia.
His Cognitive decline study also includes fields such as
- White matter which intersects with area such as Corpus callosum and Neuroscience,
- Gerontology together with Medical record.
His research on Internal medicine focuses in particular on Alzheimer's disease.
His study in Disease is interdisciplinary in nature, drawing from both Stage, Pediatrics and Neuropsychology.
His biological study spans a wide range of topics, including Fractional anisotropy, Neurodegeneration and Amyloidosis.
Between 2019 and 2021, his most popular works were:
- Progressive dysexecutive syndrome due to Alzheimer’s disease: a description of 55 cases and comparison to other phenotypes (16 citations)
- Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes. (12 citations)
- Imaging Biomarkers of Alzheimer Disease in Multiple Sclerosis. (9 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Alzheimer's disease
- Disease
Mary M. Machulda mainly focuses on Disease, Alzheimer's disease, Dementia, Internal medicine and Logopenic progressive aphasia.
His research in Alzheimer's disease tackles topics such as Standardized uptake value which are related to areas like Depression, Cognitive decline, Prospective cohort study, Hazard ratio and Proportional hazards model.
Dementia is the subject of his research, which falls under Pathology.
His Internal medicine research includes elements of Multiple sclerosis and Neurology.
His Logopenic progressive aphasia research incorporates elements of Functional networks, Posterior cortical atrophy, Neuroimaging, Primary progressive aphasia and Atrophy.
As part of one scientific family, Mary M. Machulda deals mainly with the area of Apolipoprotein E, narrowing it down to issues related to the Amyloid β, and often Pittsburgh compound B.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
